UK Markey Cancer Center’s Molecular Tumor Board identified possible hereditary genetic mutations in 12% of patients with cancer who underwent tumor DNA testing.
This “UK at the Half” features two students who were selected as CURE Fellows to develop new knowledge and skills through research within UK’s Research Priority Areas.
A groundbreaking lung cancer screening project co-led by UK's Markey Cancer Center and the University of Colorado Cancer Center is set to expand its reach.
UK Markey Cancer Center expert Nathan Vanderford, Ph.D., is contributing to a critical national discussion on sustaining and supporting the cancer workforce.
The research study is the first to show that long-term PFOS exposure can lead to changes in intestinal cells that are linked to the development of cancer.
